StockVS

NASDAQ · Shell Companies · USD

Aimei Health Technology Co., Ltd (AFJK) Stock Analysis

Aimei Health Technology Co., Ltd (AFJK) is a Shell Companies stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 20, 2026

AFJK

$12.10

−$0.17 (−1.39%)

Oct 20, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare AFJK with… →

AFJK Key Statistics

As of Oct 20, 2026
Trading
Open
$12.01
Previous Close
$12.27
Day's Range
11.91–12.10
52-Week Range
6.75–130.37
Volume
1.25K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.91
Valuation
Market Cap
$37.71M
P/E Ratio
170.14
EPS (ttm)Profit attributable to each share over the last twelve months.
0.07
Financials (FY)
Revenue (FY)
$0.00
Net Income (FY)
$1.06M−58.48%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
3.17M
1-Year Return
+6.14%
Dividend and dates
Avg Volume
20.14K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 20, 2026, AFJK closed at $12.10, +6.14% over 1 year.

Aimei Health Technology Co., Ltd (AFJK) has a market capitalization of $37.71M.

In fiscal 2025, AFJK reported revenue of $0.00.

AFJK Stock Return by Calendar Year

Aimei Health Technology Co., Ltd (AFJK) return since Jan 2024: what $10,000 became

1 year
$10,000 $10,614
+6.14%
Since Jan 2024
$10,000 $11,921
+19.21%

If you had invested $10,000 in Aimei Health Technology Co., Ltd (AFJK) at the close on January 22, 2024, the earliest close on record here, it would have been worth $11,921 at the close on October 20, 2026: +19.21% in total, +6.62% a year, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−81.10%
2025+498.22%
2024+5.42%

As of October 20, 2026.

AFJK Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$0.00$1.06M—
2024$0.00$2.55M—
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$0.00—−$835.76K$1.06M—
2024$0.00—−$1.06M$2.55M—

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

AFJK Valuation vs Shell Companies Median

Median of 309 stocks
MetricAFJKShell Companies medianvs median
P/E170.1449.163.5x the median

Medians across 309 Shell Companies stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Aimei Health Technology Co., Ltd (AFJK) is capitalised at $37.71M on the latest close. It is classified in the Shell Companies industry, within the Financial Services sector.

AFJK last closed at $12.10 on October 20, 2026. That is −$0.17 (−1.39%) against the previous close. The 52-week range on file runs from $6.75 to $130.37. The latest close sits 79.26% above that 52-week low.

Financial Health

In fiscal 2025, Aimei Health Technology Co., Ltd reported revenue of $0.00. Net income for the same year was $1.06M. That is −58.48% against the prior fiscal year. Earnings per share on a trailing basis come to 0.07.

Valuation Assessment

On trailing earnings, the shares are priced at 170.14 times earnings. That is 3.5 times the Shell Companies median of 49.16. The medians here are taken across 309 Shell Companies companies that report the metric.

Beta against the wider market is reported at 0.91. Daily returns over the trailing 2 years annualize to a volatility of 736.87%. Over the trailing twelve months the total return is +6.14%. The stored price history starts on January 22, 2024, and the total return since then is +19.21%.

Growth & Income

The record shows no dividend for AFJK.

2026 is still running; the total return is −81.10% year to date. The strongest complete calendar year on file is 2025 at +498.22%; the weakest is 2024 at +5.42%.

Peer Comparison

Aimei Health Technology Co., Ltd (AFJK) operates in the Shell Companies industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Aimei Health Technology Co., Ltd AFJK $37.71M 170.1
Vylor Inc. VYLR $49.89B 106.8
Drugs Made In America Acquisition II Corp. DMII $649.10M 34.0
Churchill Capital Corp XI CCXI $621.61M —

The Shell Companies industry average P/E ratio is 49.2x. Aimei Health Technology Co., Ltd trades at a P/E of 170.1.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 20, 2026.

Related Shell Companies Stocks

View all Shell Companies stocks →

Popular Financial Services Stocks

View all Financial Services stocks →

About Aimei Health Technology Co., Ltd

Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition stock purchase, reorganization, or similar business combination with one or more businesses. It also intends to acquire small cap businesses in the biopharmaceutical, medical technology and device industries, as well as in the diagnostic and other service sectors. Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.